cached image

Lori Ferrins, Ph.D.

Affiliations: 
2015- Northeastern University, Boston, MA, United States 
Area:
Trypanosomiasis
Google:
"Lori Ferrins"
Mean distance: 9.62
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

de Oliveira RG, Cruz LR, Dessoy MA, et al. (2025) Discovery and Early Optimization of 1-Indole-2-carboxamides with Anti- Activity. Journal of Medicinal Chemistry
Toynton A, Ferrins L, Newson HL, et al. (2025) Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas. Rsc Medicinal Chemistry
Spaulding A, Sharma A, Giardini MA, et al. (2025) Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents. Acs Infectious Diseases
Ferrins L, Diaz R, Cordon-Obras C, et al. (2024) Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of . Journal of Medicinal Chemistry. 67: 13985-14006
Klug DM, Tse EG, Silva DG, et al. (2023) Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant . Acs Infectious Diseases
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1304196
Boby ML, Fearon D, Ferla M, et al. (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science (New York, N.Y.). 382: eabo7201
Dichiara M, Simpson QJ, Quotadamo A, et al. (2023) Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. Acs Infectious Diseases
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1149145
Sanders BC, Pokhrel S, Labbe AD, et al. (2023) Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nature Communications. 14: 1733
See more...